The majority of people diagnosed with the disease are over the age of 65, but rare cases of early-onset Alzheimer’s do occur.

Science minister Sir Patrick Vallance said he was "super excited" by advancements in dementia diagnosis and treatment ...

Village Caregiving reports that frontotemporal dementia is a progressive brain disease affecting behavior, speech, and memory ...

Lecanemab is the first medication approved in Canada that targets the buildup of amyloid plaque in the brain, which is ...

A new drug to treat Alzheimer’s Disease has been approved by Health Canada and it is the first drug that targets an ...

On Real Possibilities with AARP Michigan, associate professor of translational neuroscience Dr. Scott Counts from Michigan ...

One of the most frightening things about Alzheimer's disease is how difficult it is to diagnose early. Now, University of ...

Early detection of Alzheimer's disease has come a step closer thanks to a new measurement method developed by chemists at ...

They were enjoying traveling the world when she was struck by early-onset Alzheimer’s disease. Now, the Summerville couple ...

For the first time, Health Canada has approved a new drug that targets the underlying cause of early-onset Alzheimer's disease. As health reporter Katherine Ward explains, doctors say this marks a ...

TORONTO – Health Canada has authorized a drug shown to slow the progression of Alzheimer’s disease.   Lecanemab is the first ...

The Justice Department unexpectedly dropped charges against a neuroscientist indicted for defrauding the NIH of approximately ...